Is the Hemp Bill Dead? The Honest Answer (And What You Should Do Anyway)
“Is the Hemp bill dead?” headlines are great for clicks and terrible for planning. The reality is simpler: in Congress, most bills are “dead” until they aren’t—and most “sure things” quietly die in committee. Bottom line: assume no rescue is coming on your preferred timeline, and run your business like the rules could tighten with […]
Wisconsin Schedule III Cannabis: What It Really Means (and What It Doesn’t)
If marijuana moves to Schedule III federally, Wisconsin headlines will be loud. The reality is quieter: Schedule III does not legalize cannabis in Wisconsin. It changes federal posture and economics—but Wisconsin still needs a state program, state rules, and state license windows before anyone can legally operate a “Wisconsin dispensary.” Here’s the practical playbook for […]
Indiana Schedule III Cannabis: Why Federal Rescheduling Won’t Legalize Hoosier Marijuana
When marijuana moves to Schedule III, Indiana businesses will ask the same question: “So… can we finally operate legally?” In Indiana, the honest answer is: not unless Indiana law changes. Federal rescheduling can change momentum, but it does not create an Indiana licensing window by magic. 1) Schedule III: a federal reclassification, not a permission […]
Tennessee Schedule III Cannabis: The Trigger Is Real — But It’s Not Instant Legalization
Tennessee Schedule III Cannabis: The Trigger Is Real — But It’s Not Instant Legalization Tennessee is one of the few states that baked a key idea into its planning: federal rescheduling/descheduling can be a trigger for state program design. But here’s the nuance: even if marijuana becomes Schedule III, Tennessee still needs legislation, agencies, rules, […]
Breach of Contract in Cannabis Deals: How Courts Actually Treat Your Agreements
The cannabis industry is booming across state-legal markets, but what happens when a deal goes bad? Breach of contract in cannabis businesses is more complex than most industries due to federal vs. state legal conflicts. Enforcing a contract in the cannabis business isn’t always business-as-usual. Cannabis operators, investors, and entrepreneurs must contend with a legal […]
Virginia Cannabis Microbusiness License (2026 Guide)
Virginia cannabis microbusiness license rules are finally taking shape as the Commonwealth prepares to launch adult-use cannabis sales in 2026. Virginia is finally moving toward a regulated adult-use cannabis market—but not in the way most people expected back in 2021. Instead of opening the floodgates to large, vertically integrated operators, lawmakers are prioritizing a microbusiness […]
Inflated THC Potency Lawsuits in 2025: What Cannabis Operators Need to Know
Inflated THC Potency Lawsuits are no longer a fringe theory – they are becoming one of the fastest ways for regulators, competitors, and consumers to attack cannabis businesses in 2025. When THC percentages on labels are inflated, plaintiffs now frame those numbers as fraud, unfair competition, and even RICO. If your COAs and labels look […]
Why the Hemp Loophole Defense Just Failed in Federal Court
Why the Hemp Loophole Defense Just Failed in Federal Court If you’ve been told that the hemp loophole defense will protect your THCA or “Farm Bill compliant” business in federal court, the Lucas Sirois case out of Maine should make you very uncomfortable. In November 2025, a federal jury convicted Sirois on every major count—conspiracy […]
Hemp Clone Loophole: How Congress Missed It In 2025
The new hemp clone loophole appears in Congress’s latest hemp rewrite, where “hemp” is defined by total THC at the time of testing but largely ignores clones, mother plants, and tissue culture. A young cannabis clone that tests under 0.3% total THC is treated as legal hemp—even if it will later produce high-THC flower—creating a […]
Hemp banking after FinCEN guidance
The new federal funding bill didn’t just tweak hemp’s definition—it rewired hemp banking. Congress added a 0.4 mg total THC cap per container, banned most synthetic or converted cannabinoids, and told FDA/HHS to classify “THC-like” compounds. When that new definition kicks in, FinCEN’s existing hemp and marijuana guidance will push many intoxicating hemp brands out […]